Lipids in circulating tumor cells from colon tumors

Lipids in circulating tumor cells from colon tumors - CTC Colon

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038654

Enrollment

Registered

2025-12-15

Start date

2026-09-01

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C18.9

Interventions

Group 1: After obtaining written consent for the study, an additional 10 ml of blood is taken from patients with colon tumours during a routine blood test. Circulating tumour cells (CTCs) are then iso

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: metastatic colon cancer

Exclusion criteria

Exclusion criteria: Chemotherapy less than 14 days prior to blood sampling

Design outcomes

Primary

Measure	Time frame
Collection of lipidome data from at least five CTC cell lines and their molecularly genetically modified subcell lines and correlation with CTC markers.	—

Secondary

Measure	Time frame
Characterization of CTC cells according to changes in the lipidome due to overexpression/downregulation of enzymes of the lipid metabolism.	—

Countries

Germany

Contacts

Public ContactChristine Koch

Universitäres Centrum für Tumorerkrankungen (UCT) Frankfurt

christine.koch@unimedizin-ffm.de+496963014917

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026